Showing results (161-170 of 189) with videos related to
Sort By:
Pageof 19
Lancet (London, England)|September 1, 1990
Inconsistencies in clinical decisions in obstetricsJ F Barrett, G J Jarvis, H N Macdonald, et al.American Journal of Obstetrics and Gynecology|August 15, 2000
Fetal response to maternally administered morphineE A Kopecky, M L Ryan, J F Barrett, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 27, 2002
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureusB M Ryan, C E Mazzucco, L E Lawrence, et al.Journal of Medicinal Chemistry|October 28, 1997
Protein structure determination using a combination of comparative modeling and NMR spectroscopy. Application to the response regulator protein, Spo0FB L Podlogar, G C Leo, P A McDonnell, et al.Cancer Research|October 27, 1997
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapyB W Henderson, D A Bellnier, W R Greco, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
DNA gyrase inhibitory activity of ellagic acid derivativesM A Weinder-Wells, J Altom, J Fernandez, et al.The Journal of Antimicrobial Chemotherapy|August 2, 2001
The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analoguesL E Lawrence, P Wu, L Fan, et al.Lasers in Surgery and Medicine|March 14, 2002
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapyJ Lobel, I J MacDonald, M J Ciesielski, et al.Antimicrobial Agents and Chemotherapy|April 1, 1992
In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinK P Fu, S C Lafredo, B Foleno, et al.Advances in Experimental Medicine and Biology|January 1, 1995
A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyraseJ J Hilliard, H M Krause, J I Bernstein, et al.Pageof 19